학술논문
Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Document Type
Article
Author
Source
In Annals of Oncology March 2017 28(3):497-504
Subject
Language
ISSN
0923-7534